December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Aelis Farma

Recent news which mentions Aelis Farma

After Four Weeks, New Drug Shows Promising Results In Boosting Life Skills For Down Syndrome Patients
Tickers NEWS
Tags Benzinga Torre Fornell premium
From Benzinga
French Biotech Candidate For Cannabis Use Disorder Fails Phase 2B Clinical Trial, Indivior Will Not Exercise Option
Tickers CDU INDV NEWS
Tags premium cannabis use disorder study CDU
From Benzinga
Study Reveals Groundbreaking Treatment For Cannabis Use Disorder With A New Class Of Medication
Tags NIDA Market News AEF0117
From Benzinga
Aelis Farma's Drug Candidate For the Treatment Of Cognitive Disorders Authorized For The First Trial In People With Down Syndrome
Tags News Cannabis AEMPS
From Benzinga
Indivior Positioned To Profit If Aelis Farma's Study Of Cannabis Use Disorder Succeeds
Tickers INVVY
Tags Indivior PLC Aelis Farma Market News
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.